| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1007/S00268-011-0956-3 |
| P698 | PubMed publication ID | 21267566 |
| P2093 | author name string | Mohammed Keshtgar | |
| Giuliano Mariani | |||
| Stanley P L Leong | |||
| Charles E Cox | |||
| John J Zaknun | |||
| Durre Sabih | |||
| Graciela Lago | |||
| P2860 | cites work | Sentinel lymph node biopsy for breast cancer using methylene blue dye manifests a short learning curve among experienced surgeons: a prospective tabular cumulative sum (CUSUM) analysis | Q33403368 |
| Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group | Q33752235 | ||
| Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. | Q34145639 | ||
| Breast cancer incidence in South Africa | Q34372156 | ||
| Clinical role of sentinel-lymph-node biopsy in breast cancer | Q34571629 | ||
| Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category | Q34577423 | ||
| Contraindications of sentinel lymph node biopsy: are there any really? | Q35634145 | ||
| American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer | Q36255725 | ||
| Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis | Q36331580 | ||
| Pathologic examination of the axillary sentinel lymph nodes in patients with early-stage breast carcinoma: current and resolving controversies on the basis of the European Institute of Oncology experience | Q36346082 | ||
| Acral lentiginous melanoma: a clinicoprognostic study of 126 cases. | Q36566703 | ||
| Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients | Q36613891 | ||
| Skin cancer in individuals of African, Asian, Latin-American, and American-Indian descent: differences in incidence, clinical presentation, and survival compared to Caucasians | Q36764670 | ||
| The rationale for sentinel-node biopsy in primary melanoma | Q36952297 | ||
| Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic | Q37521168 | ||
| Breast cancer incidence and determinants of cancer stage in the Western Cape. | Q39560475 | ||
| Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update | Q42525218 | ||
| A synthetic macromolecule for sentinel node detection: (99m)Tc-DTPA-mannosyl-dextran. | Q43629008 | ||
| Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma | Q43684203 | ||
| [(99m)Tc]MAG(3)-mannosyl-dextran: a receptor-binding radiopharmaceutical for sentinel node detection | Q43715444 | ||
| A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer | Q43799351 | ||
| The revised American Joint Committee on Cancer staging system for melanoma | Q44096425 | ||
| Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial | Q44478647 | ||
| Preclinical studies of [(99m)Tc]DTPA-mannosyl-dextran . | Q44494926 | ||
| Dose-dependent biodistribution of [(99m)Tc]DTPA-mannosyl-dextran for breast cancer sentinel lymph node mapping | Q44708778 | ||
| Sentinel lymph node biopsy assessment using intraoperative imprint cytology in breast cancer patients: results of a validation study | Q45162953 | ||
| The impact of lymphoscintigraphy technique on the outcome of sentinel node biopsy in 1,313 patients with cutaneous melanoma: an Italian Multicentric Study (SOLISM-IMI). | Q45168906 | ||
| Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial | Q45287919 | ||
| Sentinel lymph node biopsy after preoperative chemotherapy for breast cancer: findings from the Austrian Sentinel Node Study Group. | Q46189953 | ||
| Implications of popliteal lymph node detected by sentinel lymph node biopsy | Q46446669 | ||
| Randomized clinical trial comparing blue dye with combined dye and isotope for sentinel lymph node biopsy in breast cancer | Q46820900 | ||
| "Westernizing" women's risks? Breast cancer in lower-income countries | Q47719867 | ||
| Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study | Q49186640 | ||
| Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial | Q50455691 | ||
| Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial | Q50464953 | ||
| Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. | Q50510780 | ||
| Learning sentinel node biopsy: results of a prospective randomized trial of two techniques. | Q50516319 | ||
| Comparative evaluation of an extensive histopathologic examination and a real-time reverse-transcription-polymerase chain reaction assay for mammaglobin and cytokeratin 19 on axillary sentinel lymph nodes of breast carcinoma patients. | Q50652755 | ||
| Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. | Q52040414 | ||
| Molecular staging of the sentinel lymph node in melanoma patients: correlation with clinical outcome. | Q53661076 | ||
| Prognostic significance of detecting micrometastases by tyrosinase RT/PCR in sentinel lymph node biopsies: lessons from 322 consecutive melanoma patients. | Q53999736 | ||
| Molecular analysis improves sensitivity of breast sentinel lymph node biopsy: results of a multi-institutional prospective cohort study. | Q54637375 | ||
| Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial | Q56553878 | ||
| Axillary metastases in breast cancer patients with negative sentinel nodes: A follow-up of 3548 cases | Q56779338 | ||
| Reverse transcription-polymerase chain reaction assay for multiple mRNA markers in the detection of breast cancer metastases in sentinel lymph nodes | Q56779726 | ||
| Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy for Advanced Breast Cancer: Results of Ganglion Sentinelle et Chimiothérapie Neoadjuvante, a French Prospective Multicentric Study | Q58051894 | ||
| The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures | Q59721943 | ||
| Preoperative chemotherapy in operable breast cancer | Q72220610 | ||
| Acral lentiginous melanoma | Q72362711 | ||
| Radiation safety of the sentinel lymph node technique in breast cancer | Q73774336 | ||
| Intraoperative evaluation of sentinel lymph nodes for metastatic melanoma by imprint cytology | Q79745676 | ||
| Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection | Q81299717 | ||
| Timing of sentinel lymph node biopsy in patients receiving neoadjuvant chemotherapy for breast cancer | Q81748234 | ||
| Axillary staging prior to neoadjuvant chemotherapy for breast cancer: predictors of recurrence | Q81952356 | ||
| Intraoperative touch imprint cytology for the diagnosis of sentinel lymph node metastases in breast cancer | Q82896665 | ||
| Low axillary sampling in clinically node-negative operable breast cancer | Q83896251 | ||
| P433 | issue | 6 | |
| P921 | main subject | lymph node | Q170758 |
| biopsy | Q179991 | ||
| P304 | page(s) | 1159-68; discussion 1155-8 | |
| P577 | publication date | 2011-06-01 | |
| P1433 | published in | World Journal of Surgery | Q15763279 |
| P1476 | title | Implementing sentinel lymph node biopsy programs in developing countries: challenges and opportunities | |
| P478 | volume | 35 |
| Q48139772 | A Comparative Validation of Primary Surgical Versus Post-neo-adjuvant Chemotherapy Sentinel Lymph Node Biopsy for Stage III Breast Cancers. |
| Q36247829 | A receptor-targeted fluorescent radiopharmaceutical for multireporter sentinel lymph node imaging |
| Q35014008 | Accuracy and validity of sentinel lymph node biopsy for breast cancer using a photosensitizer: 8-year follow-up |
| Q86891415 | Assessing patterns of practice of sentinel lymph node biopsy for breast cancer in Latin America |
| Q26795628 | Developing the Evidence Base to Inform Best Practice: A Scoping Study of Breast and Cervical Cancer Reviews in Low- and Middle-Income Countries |
| Q38381761 | Global health perspective on gynecologic oncology |
| Q40108098 | Planning cancer control in Latin America and the Caribbean |
| Q91629028 | Sentinel Lymph Node Biopsy Pathology and 2-Year Postsurgical Recurrence of Breast Cancer in Kenyan Women |
Search more.